Answer

What Are the Rules for Medical Weight Loss Clinic Ads on Meta and Google?

Reviewed September 16, 20266 min readBy Michael Borgia, MedScale Health

Short answer

As of September 2026, a medical weight loss clinic can advertise its program on Meta and Google today, and gets restricted for three things: naming semaglutide, tirzepatide or a brand like Ozempic in ad copy or keywords without certification, transformation imagery or idealised bodies, and second-person hooks such as "tired of the weight?" that trip Meta's personal attributes standard. Weight-loss ads must target adults only. MedScale Health, a patient-acquisition agency for telehealth and clinics, keeps the drug on the page and the program in the ad.

What this means for you

  • Name the program and the supervision in the ad. Keep the molecule and the brand names on the landing page, out of ad text and keyword lists, until you hold certification.
  • Target adults only on every platform. Meta's health and wellness standard requires it for weight-loss advertising, and a mis-set ad set fails on its own.
  • No transformation imagery, no numbers on a scale, no isolated body-part close-ups, no "you". Provider-to-camera and program explainers are the formats that survive.
  • If your program includes compounded semaglutide or tirzepatide, say "compounded, not FDA-approved" wherever it is named, and never imply it is the same as the branded drug.
  • Pixel events named after the drug pull the account into restricted delivery. Name them generically.

MedScale Health, a patient-acquisition agency for telehealth and clinics, treats medical weight loss as the highest-intent search demand in local healthcare and the fastest way to get an ad account restricted when the creative is built like a supplement ad. The rules below are the ones that produce those restrictions. This page is marketing guidance for healthcare operators. It is not medical or legal advice, and platform policies change: check the sources listed at the end before acting on any specific rule.

Meta: three standards, one age rule

Meta's health and wellness standard requires weight-loss advertising to be targeted to people 18 or older, prohibits statements of inferiority about physical appearance, prohibits close-ups of a specific body area, and treats exaggerated or extreme claims as clickbait. The personal attributes standard prohibits copy that asserts or implies a viewer's medical condition or physical characteristics; Meta's own examples make the point that a program can be described but the reader cannot be diagnosed. The drugs and pharmaceuticals standard applies the moment an ad or a page promotes a prescription medication: LegitScript certification and Meta's authorization are required, and the advertising must be to adults.

A clinic that only ever advertises its supervised program can run under the first two standards without certification. The third standard is triggered by naming the drug, by a landing page that lists medications with prices, or by a pixel that reports a medication event. Clinics are usually restricted by the page, not the ad.

Google: program intent is open, drug terms are certified

Google's healthcare and medicines policy restricts prescription drug terms. Semaglutide, tirzepatide and brand names in ad text or keywords are rejected automatically unless the advertiser holds Google's prescription drug services certification, which in the United States requires LegitScript first. Misspellings and spacing tricks to get past the filter are circumvention, and circumvention is the label that ends accounts rather than ads.

Program and clinic intent is open: "medical weight loss clinic near me", "GLP-1 program", "physician supervised weight loss". Those campaigns are where a clinic starts, with location-level budgets and call tracking tied to the booked consult, and the drug-name pages ranking organically instead of being bid on. Where the clinic ships medication and wants the drug terms, certification runs alongside the live campaigns.

Compounded semaglutide and tirzepatide: the claims that draw letters

In 2026 the FDA warned 30 telehealth companies over the marketing of compounded GLP-1 products, citing claims that presented compounded drugs as FDA-approved, implied they were the same as the branded products, and omitted safety information. Compounded products are, by definition, compounded, not FDA-approved. A clinic that offers them says so wherever they are named, does not compare them to the branded drug, and does not make efficacy claims it cannot support. The same claims are LegitScript rejection reasons, so a page that would draw an FDA letter also blocks certification.

The landing page decides the account's tier

Both platforms read the destination as part of the ad, and Meta categorises the data source by what the site is about. A page that lists medications with prices and a checkout is an online pharmacy in that reading, and the restriction that follows applies to conversion events across the account, which is why cost per consult climbs after a clinic "just added" a medication menu. The compliant structure puts the clinic and the supervised program first, medication detail second, candidacy and pricing framed the way the platforms allow, and a prescription-required statement, provider credentials and a results-vary line on every page an ad can land on.

Creative that passes review

  • Provider-to-camera explaining how the program works, who it is for and what the first month involves.
  • Program and process imagery: the consultation, the intake, the clinic, the follow-up cadence.
  • Brand-voice copy with the program as the subject. "The program includes weekly check-ins" passes; "struggling with your weight?" does not.
  • Testimonials about the experience of care, not about physical change.
  • Adults-only targeting set at the ad set, checked before every launch.

TikTok

Prescription drugs are prohibited as an ad subject in most markets and weight-management products are restricted. TikTok is useful for clinic brand awareness with provider-led content and rarely for direct response. A clinic should verify any weight-loss exception with its TikTok representative before relying on it.

Search structure for a clinic without certification

A weight loss clinic that does not hold Google's prescription drug services certification still owns the highest-intent local search demand in healthcare, provided the campaign is built on the queries that are open. Program intent ("medical weight loss program", "GLP-1 clinic"), supervision intent ("doctor supervised weight loss") and location intent ("weight loss clinic near me") run in separate ad groups with location-level budgets. The drug-name queries the clinic cannot bid on are answered by organic pages that explain the medication options a prescriber may consider, which rank for those searches without a single paid impression. Search terms are reviewed weekly and any drug-name term that Google matched to a program keyword is added as a negative, because the ad that served against it is the one that draws the disapproval.

Why the disapproval pattern matters more than any single rejection

A rejected ad costs a day. A pattern of rejections in the same policy area costs the account, because repeated violations signal to Meta's systems that the advertiser is not operating within policy, and enforcement then extends beyond the ad to the account and to linked assets in the same business. Clinics rarely lose accounts to one egregious ad; they lose them to a third creative round that reintroduced the second-person hook, resubmitted twice, followed by a landing page update that added the medication menu. Disapproval rate is therefore tracked as a leading risk indicator, every rejection is rewritten rather than re-filed, and any change to the landing page goes through the same policy read as the ads.

The intake decides what the ad spend was worth

A weight loss clinic's paid traffic is only as valuable as the intake it lands on. A qualification flow that asks the candidacy questions before the consult (age, state, history, contraindications, self-pay or insurance) filters out the people the prescriber cannot treat before a slot is booked, so clinicians are not paid to say no. Every step of that flow fires a generic server-side event, and no third-party pixel reads a health field, so the booked consult rather than the form fill is what the campaign gets credit for. The clinics that report the best cost per consult are rarely the ones with the cleverest ads; they are the ones whose intake and tracking let the platforms optimise toward the right outcome.

What MedScale does

MedScale Health runs medical weight loss clinic acquisition as described on medscale.health/clinics/medical-weight-loss: search campaigns built on program and clinic intent with drug-name pages ranking organically, Meta creative pre-cleared against the health and personal attributes standards, an intake flow that filters for candidacy before the consult, and server-side tracking on every step with no third-party pixel touching a health field. Where a clinic wants to bid on drug terms, the certification runs alongside the campaign rather than ahead of it.

Common questions

01Can a weight-loss clinic name semaglutide or Ozempic in its ads?
On Google, not without prescription drug services certification, and brand names are trademarked drug terms that draw legal risk on top of policy risk. On Meta, naming a prescription drug classifies the ad as pharmaceutical promotion, which requires LegitScript certification and authorization. Most clinics are better served naming the program and letting the page carry the medication detail.
02Why did our clinic's Meta account get restricted when we only advertise a service?
Usually the site, not the ad. Meta categorises advertisers by what the landing page looks like; a page that reads like an online pharmacy triggers the drugs standard and restricts conversion events. Page structure, pixel event names and the claims on the page all matter.
03Do we need LegitScript to run Google Ads for a weight-loss clinic?
No, for program and clinic intent keywords, which are open. Yes, for drug-name keywords and ad text, because Google's prescription drug services certification in the United States requires LegitScript first.
04Can we say our compounded semaglutide is the same as Wegovy?
No. Compounded products are not FDA-approved, and the FDA's 2026 warning letters to telehealth companies cited exactly that kind of sameness claim. State the compounded status plainly, avoid comparisons to branded drugs, and keep efficacy claims to what you can support.
05Is a weight-loss testimonial allowed in a Meta ad?
A testimonial about the experience of care, such as convenience or clinician access, can run. A testimonial about physical change, a number lost, or an idealised result fails the health and wellness standard and, under FTC rules, has to reflect what a typical customer can expect.

Sources

  1. 01Meta Advertising Standards: Health and wellnesschecked September 16, 2026
  2. 02Meta Advertising Standards: Privacy violations and personal attributeschecked September 16, 2026
  3. 03Meta Advertising Standards: Drugs and pharmaceuticalschecked September 16, 2026
  4. 04Google Ads policy: Restricted drug termschecked September 16, 2026
  5. 05Google Ads policy: Healthcare and medicineschecked September 16, 2026
  6. 06FDA press announcement: FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1schecked September 16, 2026
  7. 07TikTok Ads policy: Healthcare and pharmaceuticalschecked September 16, 2026

Related answers

Last reviewed September 16, 2026. Platform policies change often; we re-verify every answer quarterly.

Growth audit

See where your growth is leaking.

We audit the funnel, the tracking, and the compliance posture, then hand you the roadmap. The people writing it have run the same funnel from the inside. You keep it whether or not we work together.

Reviewed
Funnel, tracking, and compliance posture
Discussed
One 30-minute call with the operator on your account
Delivered
A written roadmap within 5 business days